These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31758966)

  • 1. Modelling epidemics with fractional-dose vaccination in response to limited vaccine supply.
    Chen Z; Liu K; Liu X; Lou Y
    J Theor Biol; 2020 Feb; 486():110085. PubMed ID: 31758966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractional dosing of yellow fever vaccine to extend supply: a modelling study.
    Wu JT; Peak CM; Leung GM; Lipsitch M
    Lancet; 2016 Dec; 388(10062):2904-2911. PubMed ID: 27837923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should yellow fever vaccine be included in the expanded program of immunization in Africa? A cost-effectiveness analysis for Nigeria.
    Monath TP; Nasidi A
    Am J Trop Med Hyg; 1993 Feb; 48(2):274-99. PubMed ID: 8447531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015-16: a modelling study.
    Kraemer MUG; Faria NR; Reiner RC; Golding N; Nikolay B; Stasse S; Johansson MA; Salje H; Faye O; Wint GRW; Niedrig M; Shearer FM; Hill SC; Thompson RN; Bisanzio D; Taveira N; Nax HH; Pradelski BSR; Nsoesie EO; Murphy NR; Bogoch II; Khan K; Brownstein JS; Tatem AJ; de Oliveira T; Smith DL; Sall AA; Pybus OG; Hay SI; Cauchemez S
    Lancet Infect Dis; 2017 Mar; 17(3):330-338. PubMed ID: 28017559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the number of unvaccinated Chinese workers against yellow fever in Angola.
    Wilder-Smith A; Massad E
    BMC Infect Dis; 2018 Apr; 18(1):185. PubMed ID: 29665797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late or Lack of Vaccination Linked to Importation of Yellow Fever from Angola to China.
    Song R; Guan S; Lee SS; Chen Z; Chen C; Han L; Xu Y; Li A; Zeng H; Ye H; Zhang F
    Emerg Infect Dis; 2018 Jul; 24(7):1383-6. PubMed ID: 29723485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yellow fever cases in Asia: primed for an epidemic.
    Wasserman S; Tambyah PA; Lim PL
    Int J Infect Dis; 2016 Jul; 48():98-103. PubMed ID: 27156836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An SIR epidemic model with vaccination in a patchy environment.
    Cui Q; Qiu Z; Ding L
    Math Biosci Eng; 2017 Oct/Dec 1; 14(5-6):1141-1157. PubMed ID: 29161854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INFECTIOUS DISEASES. Yellow fever outbreak triggers vaccine alarm.
    Kupferschmidt K
    Science; 2016 Apr; 352(6282):128-9. PubMed ID: 27124428
    [No Abstract]   [Full Text] [Related]  

  • 10. [Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997].
    da Silva A; Parent du Châtelet I; Beckr Gaye A; Dompnier JP; Seck I
    Sante; 2003; 13(4):215-23. PubMed ID: 15047438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO position on the use of fractional doses - June 2017, addendum to vaccines and vaccination against yellow fever WHO: Position paper - June 2013.
    World Health Organization
    Vaccine; 2017 Oct; 35(43):5751-5752. PubMed ID: 28689653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global Risk and Elimination of Yellow Fever Epidemics.
    Ndeffo-Mbah ML; Pandey A
    J Infect Dis; 2020 Jun; 221(12):2026-2034. PubMed ID: 31545372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal vaccination and treatment policies for regional approximate controllability of the time-fractional reaction-diffusion SIR epidemic systems.
    Ge F; Chen Y
    ISA Trans; 2021 Sep; 115():143-152. PubMed ID: 33487399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability Analysis of an Extended SEIR COVID-19 Fractional Model with Vaccination Efficiency.
    Wali M; Arshad S; Huang J
    Comput Math Methods Med; 2022; 2022():3754051. PubMed ID: 36176740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccinating in disease-free regions: a vaccine model with application to yellow fever.
    Codeço CT; Luz PM; Coelho F; Galvani AP; Struchiner C
    J R Soc Interface; 2007 Dec; 4(17):1119-25. PubMed ID: 17442650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the absence or intermittent YF vaccination the major contributor to its persistent outbreaks in eastern Africa?
    Baba MM; Ikusemoran M
    Biochem Biophys Res Commun; 2017 Oct; 492(4):548-557. PubMed ID: 28109882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notes from the Field: Knowledge, Attitudes, and Practices Regarding Yellow Fever Vaccination Among Men During an Outbreak - Luanda, Angola, 2016.
    Marlow MA; Pambasange MA; Francisco C; Receado OD; Soares MJ; Silva S; Navarro-Colorado C; Zielinski-Gutierrez E
    MMWR Morb Mortal Wkly Rep; 2017 Feb; 66(4):117-118. PubMed ID: 28151922
    [No Abstract]   [Full Text] [Related]  

  • 18. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.
    Woods CW; Armstrong G; Sackey SO; Tetteh C; Bugri S; Perkins BA; Rosenstein NE
    Lancet; 2000 Jan; 355(9197):30-3. PubMed ID: 10615888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIR epidemics and vaccination on random graphs with clustering.
    Fransson C; Trapman P
    J Math Biol; 2019 Jun; 78(7):2369-2398. PubMed ID: 30972440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractional-dose yellow fever vaccination: how much more can we do with less?
    Visser LG
    Curr Opin Infect Dis; 2019 Oct; 32(5):390-393. PubMed ID: 31335440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.